CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update Accessibility Statement Skip Navigation PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation(NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. First Qu ...